|
Video: What is a Stock Split?
|
|
Evofem Biosciences is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health, including woman-controlled contraception and protection from certain sexually transmitted infections. Co.'s commercial product, Phexxi, is the U.S. Food and Drug Administration (FDA)-approved, hormone-free, woman-controlled, prescription contraceptive gel for women. Co. is evaluating Phexxi for two potential new indications: the prevention of chlamydia and the prevention of gonorrhea in women. The FDA has designated Phexxi, using the investigational name EVO100, as a Qualified Infectious Disease Product. According to our EVFM split history records, EVFM has had 2 splits. | |
|
EVFM (EVFM) has 2 splits in our EVFM split history database. The first split for EVFM took place on January 18, 2018. This was a 1 for 6 reverse split, meaning for each 6 shares of EVFM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split. EVFM's second split took place on May 06, 2022. This was a 1 for 15 reverse split, meaning for each 15 shares of EVFM owned pre-split, the shareholder now owned 1 share. For example, a 166.666666666667 share position pre-split, became a 11.1111111111111 share position following the split.
When a company such as EVFM conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the EVFM split history from start to finish, an original position size of 1000 shares would have turned into 11.1111111111111 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into EVFM shares, starting with a $10,000 purchase of EVFM, presented on a split-history-adjusted basis factoring in the complete EVFM split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/21/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$1,012.50 |
|
End price/share: |
$0.02 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-100.00% |
|
Average Annual Total Return: |
-69.07% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.16 |
|
Years: |
9.42 |
|
|
|
Date |
Ratio |
01/18/2018 | 1 for 6 | 05/06/2022 | 1 for 15 |
|
|